Tikvah Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Tikvah Management’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-726,895	Closed	-$2.82M	–	21
2026 Q1	$2.82M	Hold	726,895	–	–	0.87%	17
2025 Q4	$1.42M	Hold	726,895	–	–	0.38%	22
2025 Q3	$614K	Hold	726,895	–	–	0.18%	22
2025 Q2	$527K	Hold	726,895	–	–	0.17%	22
2025 Q1	$626K	Hold	726,895	–	–	0.21%	24
2024 Q4	$1.22M	Hold	726,895	–	–	0.33%	23
2024 Q3	$2.07M	Hold	726,895	–	–	0.64%	23
2024 Q2	$1.7M	Hold	726,895	–	–	0.55%	23
2024 Q1	$2.14M	Hold	726,895	–	–	0.67%	21
2023 Q4	$2.17M	Sell	726,895 -587,000	-45%	-$1.68M	0.75%	20
2023 Q3	$4.15M	Hold	1,313,895	–	–	1.49%	15
2023 Q2	$5.08M	Sell	1,313,895 -175,000	-12%	-$504K	1.73%	15
2023 Q1	$4.12M	Hold	1,488,895	–	–	1.69%	15
2022 Q4	$2.68M	Hold	1,488,895	–	–	1.28%	17
2022 Q3	$3.16M	Hold	1,488,895	–	–	1.46%	16
2022 Q2	$4M	Hold	1,488,895	–	–	1.73%	15
2022 Q1	$6.46M	Buy	1,488,895 +257,060	+21%	+$1.06M	2.07%	13
2021 Q4	$6.38M	Buy	1,231,835 +523,295	+74%	+$2.8M	1.78%	13
2021 Q3	$4.35M	Buy	+708,540	New	+$5.65M	1.18%	16

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Tikvah Management's NAUT Position: Q2 2026 in Review

Tikvah Management sold out of Nautilus Biotechnolgy (NAUT) in Q2 2026, closing a stake of 726,895 shares — an estimated $2.82M sold.

Tikvah Management first reported a position in NAUT in Q3 2021 and held it in 19 quarters. The position peaked at $6.46M in Q1 2022. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Tikvah Management reported no remaining Nautilus Biotechnolgy position as of Q2 2026 after selling out during the quarter.
Tikvah Management sold 726,895 Nautilus Biotechnolgy shares in Q2 2026, an estimated $2.82M.
Tikvah Management first reported a position in Nautilus Biotechnolgy in Q3 2021 and held it in 19 quarters.
Tikvah Management's Nautilus Biotechnolgy position peaked at $6.46M in Q1 2022.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Tikvah Management's 13F filing for Q2 2026, filed 13 Aug 2026.